RiskImmune™ is a laboratory-developed test that may help identify patients at greater risk of anti-TNF antibody (ADAb) formation and could aid your therapeutic decision making.
www.prometheuslabs.com
RiskImmune
Inflammatory Bowel Disease Determine risk of anti-TNF immunogenicity before initiating anti-TNF therapy in IBD patients. RiskImmune™ is a laboratory-developed test that may help identify patients at greater risk of anti-TNF antibody (ADAb) formation and could aid your therapeutic...
